the hanover insurance group inc. - THG
THG
Close Chg Chg %
162.79 0.95 0.58%
Closed Market
163.74
+0.95 (0.58%)
Volume: 209.04K
Last Updated:
Nov 22, 2024, 3:59 PM EDT
Company Overview: the hanover insurance group inc. - THG
THG Key Data
Open $162.02 | Day Range 162.01 - 164.90 |
52 Week Range 119.36 - 165.28 | Market Cap $5.86B |
Shares Outstanding 36.03M | Public Float 35.71M |
Beta 0.70 | Rev. Per Employee N/A |
P/E Ratio 16.15 | EPS $10.20 |
Yield 208.92% | Dividend $0.85 |
EX-DIVIDEND DATE Sep 13, 2024 | SHORT INTEREST N/A |
AVERAGE VOLUME 181.82K |
THG Performance
1 Week | 0.07% | ||
1 Month | 10.68% | ||
3 Months | 19.16% | ||
1 Year | 34.48% | ||
5 Years | 22.45% |
THG Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
7
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 169.833 | |
Number of Ratings | 7 | Current Quarters Estimate | 3.366 | |
FY Report Date | 12 / 2024 | Current Year's Estimate | 11.396 | |
Last Quarter’s Earnings | 3.05 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 1.56 | Next Fiscal Year Estimate | 13.70 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 7 | 5 | 7 | 7 |
Mean Estimate | 3.37 | 3.61 | 11.40 | 13.70 |
High Estimates | 3.54 | 3.89 | 11.55 | 14.17 |
Low Estimate | 3.19 | 3.38 | 11.25 | 13.25 |
Coefficient of Variance | 4.53 | 5.68 | 1.12 | 2.48 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 4 | 5 | 5 |
OVERWEIGHT | 0 | 0 | 1 |
HOLD | 3 | 3 | 3 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for The Hanover Insurance Group Inc. - THG
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for The Hanover Insurance Group Inc. - THG
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Oct 4, 2024 | Jeffrey Mark Farber Executive Vice President | 85,741 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $150.02 per share | 12,862,864.82 |
May 29, 2024 | Jane D. Carlin Director | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $132.25 per share | 0.00 |
May 17, 2024 | Theodore H. Bunting Director | 5,211 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Joseph R. Ramrath Director | 32,010 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Cynthia L. Egan Director | 12,759 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Kathleen S. Lane Director | 5,778 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Elizabeth A. Ward Director | 4,059 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | James Paul Condrin Director | 4,532 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Francisco Alberto Aristeguieta Silva Director | 3,233 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 17, 2024 | Kevin J. Bradicich Director | 8,272 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 9, 2024 | Willard T. Lee Executive Vice President | 4,398 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $135.94 per share | 597,864.12 |
Apr 2, 2024 | Bryan J. Salvatore Executive Vice President | 23,516 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2024 | Denise Tinger M. Lowsley Executive Vice President | 5,689 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2024 | Warren Ellison Barnes SVP & Princpl. Accntg. Officer | 3,499 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2024 | Richard William Lavey Executive Vice President | 36,243 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2024 | Dennis F. Kerrigan Executive Vice President | 8,442 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2024 | John Conner Roche President and CEO; Director | 113,599 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 2, 2024 | David J. Lovely Executive Vice President | 1,443 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 29, 2024 | Jeffrey Mark Farber Executive Vice President | 15,332 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 29, 2024 | Richard William Lavey Executive Vice President | 35,599 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |